What are the side effects of Eltrombopag?

Eltrombopag/Eltrombopag (Eltrombopag) is a drug used to treat conditions related to thrombocytopenia, such as idiopathic thrombocytopenic purpura (ITP) and low platelet counts associated with chronic liver disease. Although it is very effective for patients in many cases, like all medications, it can cause some side effects and adverse reactions. The following are possible side effects of Eltrombopag/Eltrombopag for your reference.

Common side effects:

1.Headache: Patients may experience a headache or a slight feeling of dizziness, which is usually more common at the beginning of treatment but may lessen over time.

2.Nausea and Vomiting: Some patients may experience nausea or vomiting. This condition usually occurs early in treatment but may lessen during subsequent treatments.

3.Abdominal pain and digestive discomfort:Eltrombopag/Eltrombopag may cause abdominal pain, bloating, indigestion and other discomforts. These symptoms may be transient but may persist in some patients.

4.Diarrhea: Some patients may experience diarrhea, especially early in treatment. Proper diet and fluid intake can help reduce this discomfort.

5.Fatigue: Some patients may experience fatigue or weakness. This can be one of the common side effects of treatment.

6.Muscle or joint pain: Some patients may experience muscle or joint pain during eltrombopag/eltrombopag treatment.

Lesser but serious side effects:

1.Abnormal liver function:Eltrombopag/Eltrombopag may affect liver function. Patients should undergo regular liver function tests during treatment to ensure that the drug is not causing damage to the liver.

2.Increased risk of thrombosis: There are reports that Eltrombopag/Eltrombopag treatment may increase the risk of thrombosis in patients. Patients may need additional monitoring and evaluation to make sure their circulation is doing well.

3.Eye problems: There are reports that some patients may develop eye problems, such as blurred vision, visual impairment, etc. when using Eltrombopag/Eltrombopag. If these symptoms occur, patients should seek medical attention immediately.

4.Allergic reactions:Eltrombopag/Eltrombopag may cause allergic reactions, such as rash, urticaria, shortness of breath, etc. If patients develop allergic symptoms, they should stop taking the medication and seek medical advice.

5.Myelosuppression: Althougheltrombopag/eltrombopag works by stimulating platelet production, in rare cases it can also lead to impaired bone marrow function, thereby reducing the production of other blood cells.

The severity and frequency of these side effects may vary between individuals and often depends on the dose and duration of treatment. If you are considering or receiving eltrombopag/eltrombopag treatment, it is strongly recommended that you have a detailed discussion with your doctor to understand the potential risks and benefits, and always use the medication as recommended by your doctor. At the same time, if you experience any unusual symptoms or side effects while using the drug, you should seek medical attention immediately and inform your doctor that you are receiving eltrombopag/eltrombopag.

Eltrombopag/Eltrombopag has been launched in China and is included in medical insurance. Because medical insurance policies vary from place to place, the price after reimbursement is also different. For details, please consult the local hospital pharmacy or medical insurance bureau. EltrombopagEltrombopag/Eltrombopag is available abroad as both original and generic drugs. The original drugs include the Turkish original drug and the Indian version of the original drug. The prices of the two are almost the same, about more than 1,000 yuan. There are many versions of generic drugs, including those from India, Bangladesh, and Laos. The cheaper generic drug is Eltrombopag from Everest Pharmaceuticals in Bangladesh, which costs around a few hundred yuan. Other generic drugs are around one to two thousand yuan, and the ingredients of the original drug and the generic drug are basically the same.